SWOG clinical trial number
S2408

A Randomized Phase III Blinded Trial of lanreotide for the Prevention of Postoperative Pancreatic Fistula

1% Accrual
Accrual
1%
Open
Phase
1% Accrual
Accrual
1%
Abbreviated Title
A Randomized Phase III Blinded Trial of lanreotide for the Prevention of Postoperative Pancreatic Fistula
Activated
02/14/2025

Research committees

Palliative and End of Life Care Committee
Gastrointestinal Cancer

Reports & Approvals

Trial Locations